Bernard Fox honored with a 2024 Society for Immunotherapy of Cancer Lifetime Achievement Award – Chiles Research Institute
Chiles Research Institute shared on X:
“Congrats to Bernard Fox, Harder Family Chair for Cancer Research and leader of the Molecular and Tumor Immunology Lab, honored with a 2024 Society for Immunotherapy of Cancer (SITC) Lifetime Achievement Award in recognition of his extraordinary contributions to the field of immunotherapy!”
Read further.
Source: Chiles Research Institute/X
Bernard A. Fox is the Co-Founder, President, and CEO of UbiVac. He is an Adjunct Professor in the Department of Molecular Microbiology and Immunology, at the Knight Cancer Institute. He is also a Member of Board of Directors at Oregon Bioscience Association.
In 2012, Dr. Fox received the Harder Family Endowed Chair for Cancer Research in recognition of his efforts in translational cancer therapy.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023